216 filings
Page 4 of 11
8-K
hfc1yszok1ma1q1jce
13 Aug 19
Nephros Announces Listing on Nasdaq Capital Market
7:45am
8-K
5yd38 od8n0i6nuz2dp
7 Aug 19
Nephros Reports Second Quarter Financial Results
4:15pm
8-K
8i8d6u8g
2 Aug 19
Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July
5:01pm
8-K
gxo4f2kr
9 Jul 19
Nephros Announces Preliminary Financial Results for Second Quarter 2019 and Reverse Stock Split
4:10pm
8-K
hxctozln ux
22 May 19
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
1kri 1l595sfxj92
16 May 19
Nephros Announces $2 Million Private Placement
7:35am
8-K
05s0s
8 May 19
Nephros Reports First Quarter Financial Results
4:15pm
8-K
ihvgc5v3
2 May 19
Nephros Appoints Tom Gwydir to its Board of Directors
10:25am
8-K
rt6 7k83mkce5gefy
9 Apr 19
Nephros Announces Preliminary Financial Results for First Quarter 2019
4:15pm
8-K
lww8jq
12 Mar 19
Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
7:50am
8-K
t02cha4 o0w
13 Feb 19
Nephros Appoints Alisa Lask to its Board of Directors
12:00am
8-K
simxrlsr
9 Jan 19
Nephros Announces Preliminary Financial Results for Fiscal Year 2018
5:20pm
8-K
uj8 ue8s9
3 Jan 19
Nephros Announces Acquisition of Biocon
9:41am
8-K
r707p97lqitydol6pm
19 Dec 18
Departure of Directors or Certain Officers
4:15pm
8-K
xnxk9dcai24
10 Dec 18
Other Events
5:23pm
8-K
gc4cb99u0azgwhqyorqy
2 Oct 18
Results of Operations and Financial Condition
4:05pm
8-K
vu36w7u8onpt11kktdur
11 Sep 18
Specialty Renal Products Announces $3 Million Series A Financing
12:00am
8-K
lpgul
13 Aug 18
Nephros Appoints Oliver Spandow to its Board of Directors
4:31pm
8-K
cojc1vsoyd1tnbpk 3w
12 Jul 18
Nephros Announces Preliminary Financial Results for Second Quarter 2018
9:59am
8-K
mk3p3kf8 194dgclj
24 May 18
Departure of Directors or Certain Officers
4:15pm